Literature DB >> 28730338

Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.

Hang Liu1, Jingxuan Wang1, Minghui Zhang1, Qijia Xuan1, Zhipeng Wang2, Xin Lian3, Qingyuan Zhang4.   

Abstract

PURPOSE: Endocrine resistance limits the efficacy of anti-estrogen therapies. Notch signaling is involved in modulating tumor-associated macrophage (TAM) differentiation and is upregulated in endocrine-resistant breast cancer cells. Here, we analyzed the role of Jagged1 in the regulation of TAM polarization to investigate whether the Jagged1-Notch pathway promotes the acquisition of aromatase inhibitor (AI) resistance by upregulating TAM infiltration.
METHODS: The Jagged1 expression levels and M2 TAM infiltration density, in 203 tumor samples from ER-positive postmenopausal patients, who received AI treatment, were evaluated by immunohistochemical staining and the results were compared with clincopathological parameters and survival. The Jagged1 protein and mRNA levels were analyzed in MCF-7 and long-term endocrine-depleted (LTED) cell lines. The phenotypes of macrophage after macrophages were co-cultured with either MCF-7 or LTED cells, were evaluated using flow cytometry. Cell migration assay was performed to evaluate the mobility of cancer cells. Notch gama secretase inhibitor (GSI) RO4929097 was employed to investigate whether modulation of Notch signaling affects M2 polarization.
RESULTS: In the tumor samples, Jagged1 expression was found to be associated with a large tumor size, high histological grade, lymphatic invasion, and high Ki67 expression. Jagged1 expression was also correlated with reduced disease-free and overall survival and was positively associated with the stromal M2 TAM infiltration density in primary tumor tissues. In AI-resistance patients, M2 TAM infiltration was denser in metastatic lesions than in primary tumors. Higher Jagged1 protein and mRNA levels were also found in LTED cells, which model AI-resistant conditions in patients, compared with MCF-7 cells. Macrophages co-cultured with LTED cells expressed higher levels of M2 marker and IL-10. M2 TAM proportion was reduced when macrophages were pre-treated with GSI before co-culture.
CONCLUSIONS: The Jagged1-Notch pathway showed elevated expression in AI-resistant breast cancer cells, resulting in macrophage differentiation towards M2 TAMs and there contributing to the acquisition of AI resistance.

Entities:  

Keywords:  Aromatase inhibitor resistance; Jagged1; Prognosis; TAMs

Mesh:

Substances:

Year:  2017        PMID: 28730338     DOI: 10.1007/s10549-017-4394-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  21 in total

Review 1.  Roles of Notch Signaling in the Tumor Microenvironment.

Authors:  Antonino B D'Assoro; Roberto Leon-Ferre; Eike-Benjamin Braune; Urban Lendahl
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 2.  Notch Signaling in Macrophages in the Context of Cancer Immunity.

Authors:  Tanapat Palaga; Wipawee Wongchana; Patipark Kueanjinda
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 3.  Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.

Authors:  Fokhrul Hossain; Samarpan Majumder; Deniz A Ucar; Paulo C Rodriguez; Todd E Golde; Lisa M Minter; Barbara A Osborne; Lucio Miele
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

Review 4.  Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?

Authors:  Mahnaz Janghorban; Li Xin; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 5.  Notch-Inflammation Networks in Regulation of Breast Cancer Progression.

Authors:  Yulia Liubomirski; Adit Ben-Baruch
Journal:  Cells       Date:  2020-06-28       Impact factor: 6.600

Review 6.  Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives.

Authors:  Gillian Moore; Stephanie Annett; Lana McClements; Tracy Robson
Journal:  Cells       Date:  2020-06-20       Impact factor: 6.600

Review 7.  Moving Breast Cancer Therapy up a Notch.

Authors:  Erik W J Mollen; Jonathan Ient; Vivianne C G Tjan-Heijnen; Liesbeth J Boersma; Lucio Miele; Marjolein L Smidt; Marc A G G Vooijs
Journal:  Front Oncol       Date:  2018-11-20       Impact factor: 6.244

8.  Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.

Authors:  Ae Kyung Park; Ji Yeoun Lee; Heesun Cheong; Vijay Ramaswamy; Sung-Hye Park; Marcel Kool; Ji Hoon Phi; Seung Ah Choi; Florence Cavalli; Michael D Taylor; Seung-Ki Kim
Journal:  BMC Cancer       Date:  2019-06-11       Impact factor: 4.430

Review 9.  The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.

Authors:  Yanghong Ni; Xiaoting Zhou; Jia Yang; Houhui Shi; Hongyi Li; Xia Zhao; Xuelei Ma
Journal:  Front Cell Dev Biol       Date:  2021-05-20

Review 10.  Precision medicine for human cancers with Notch signaling dysregulation (Review).

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2019-12-04       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.